Total monthly cost: $174
4 Heart and Stroke Richard Lewar Center of Excellence in Cardiovascular Research, and 5 Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial
As a dietary supplement, it does not require FDA approval before sale
Meanwhile, semaglutide (Ozempic) is now FDAapproved for reducing the risk of kidney disease progression and renal outcomes in people with type 2 diabetes and chronic kidney disease
No Ozempic lawsuit settlement has been reached at this stage of the litigation, and any projected compensation ranges remain estimates based on comparable pharmaceutical mass tort cases involving severe gastrointestinal injuries and permanent vision loss
